Glycoproteinosis
Glycoproteinosis are lysosomal storage diseases[1] affecting glycoproteins, resulting from defects in lysosomal function. The term is sometimes reserved for conditions involving degradation of glycoproteins.[2]
| Glycoproteinosis | |
|---|---|
| Specialty | Endocrinology  |
Types
- (E77.0) Defects in post-translational modification of lysosomal enzymes
- Mucolipidosis II (I-cell disease)
- Mucolipidosis III (pseudo-Hurler polydystrophy)
- (E77.1) Defects in glycoprotein degradation
Another type, recently characterized, is galactosialidosis.[3]
gollark: All channels are the right channel at all times, <@!218047149512982531>.
gollark: If we construct a matrix of interrelated laws...
gollark: In which case, they would *all* be false.
gollark: You could, of course, interpret laws as, I don't know, US government bills.
gollark: Well, in that case, gollark's law may apply to itself.
References
- Charles H. Rodeck; Martin J. Whittle (27 October 2008). Fetal medicine: basic science and clinical practice. Elsevier Health Sciences. pp. 362–. ISBN 978-0-443-10408-4. Retrieved 3 November 2010.
- Robert V. Stick; Spencer J. Williams (2 December 2008). Carbohydrates: the essential molecules of life. Elsevier. pp. 402–. ISBN 978-0-240-52118-3. Retrieved 3 November 2010.
- Bonten EJ, Wang D, Toy JN, et al. (June 2004). "Targeting macrophages with baculovirus-produced lysosomal enzymes: implications for enzyme replacement therapy of the glycoprotein storage disorder galactosialidosis". FASEB J. 18 (9): 971–3. doi:10.1096/fj.03-0941fje. PMID 15084520.
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.